⌕
Core Scientific · CORZ · Nasdaq
Tenet 26 · Weak
Compare
$13.51−0.52%At closeTenet 26 · Weak
$13.51−0.07 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Core Scientific (CORZ) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 50% below its peak, net margin −90.5%. Worth your attention in FY25: Share count (+36.3%) and Capex step-up ($729.0M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼37.5%
319.0
FY21→FY25CAGR −12.5%/yr
Net income ($M)▲79.9%
−288.6
one-off year: see footnoteCAGR —
Free cash flow ($M)▼765.7%
−450.8
capex stepped upCAGR —
Diluted EPS▲81.9%
−0.88
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+36.3%

233.3mn → 318.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$729.0M

▲668% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)319.0Revenue−281.1COGS37.9Gross profit−159.2SG&A−245.6Op income−43.0Tax & other−288.6Net income

-90¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
503825130%sector median net margin ~25%FY21FY25

Over this window: gross 43.9% → 11.9%. Net margin -90.5% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 0.6782, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
592,074.0319,019.0510,672.0502,400.0640,313.0544,483.0▼37.5%−12.5%
Cost of revenue
347,897.0281,121.0403,336.0378,941.0631,913.0305,621.0▼30.3%−2.1%
Gross profit
244,177.037,898.0121,070.0123,459.08,400.0238,862.0▼68.7%−36.9%
Research & development
————26,962.07,674.0——
Selling, general & admin
174,047.0159,224.0113,691.0108,111.0213,280.060,486.0▲40.0%+27.4%
Total operating expenses
678,692.0283,487.0249,401.0114,498.02,117,953.0107,368.0▲13.7%+27.5%
Operating incomefeeds ROC rank
−434,015.0−245,589.0−142,065.08,961.0−2,109,553.0131,494.0▼72.9%—
Other income, net
221,702.0−42,444.0−1,294,950.0−254,765.0−53,856.0−68,419.0——
Pretax income
−212,313.0−288,033.0−1,437,015.0−245,804.0−2,163,409.063,075.0▲80.0%—
Income tax
−103,904.0583.0859.0683.0−17,091.015,763.0▼32.1%−56.1%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−108,409.0−288,616.0−1,437,874.0−246,487.0−2,146,318.047,312.0▲79.9%—
Per share
Diluted EPSbuyback-sensitive
−5.54−0.88−4.87−0.65−6.300.20▲81.9%—
Diluted shares (mn)
469.01318.07255.83379.86340.65233.31▲24.3%+8.1%
Margins
Gross margin23rd pct in Financial Services
41.2%11.9%23.7%24.6%1.3%43.9%▼11.8pp−32.0pp
Operating margin
−73.3%−77.0%−27.8%1.8%−329.5%24.2%▼49.2pp−101.1pp
Net margin2nd pct in Financial Services
−18.3%−90.5%−281.6%−49.1%−335.2%8.7%▲191.1pp−99.2pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 25% vs a −0% norm for this window, likely a one-time item; see the filing.
FY20 – FY20 · 1 more year
Unlock the full history →
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-02 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Core Scientific's revenue last fiscal year?

Core Scientific reported revenue of $319.0M in fiscal 2025, down 37.5% from fiscal 2024.

What was Core Scientific's net income?

Core Scientific reported net income of −$288.6M in fiscal 2025, a net margin of −90.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.